Insight: original analysis

Oklahoma Is the Place to Be . . . Especially for Value-Based Contracting

This article—the latest in a McDermott+Consulting series investigating the president’s drug pricing plans—takes a closer look at Oklahoma’s recently approved State Plan Amendment that allows Oklahoma to negotiate value-based contracts with drug makers for individuals covered by the state’s Medicaid plan.

ORIGINAL ANALYSIS

• Administration /
• Drug Pricing /
• Drugs /
• Oklahoma